4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-054026
CEO sold 2,804 shares at $15.81 ($44,331)
- CEO acquired 5,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2022-10-15 | Option exercise | +5,938 | 81,813 | D | ||
| DAVIS STEPHEN CEO | 2022-10-15 | Sale | −2,804 | $15.81 | $44,331 | 79,009 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2022-10-15 | Option exercise · Restricted Stock Units | −5,938 | 0 | D | ||
| Open-market sales · 2,804 sh · avg $15.81 · $44,331 | |||||||
Loading xslF345X03/doc4.xml…